NOVARTIS AG-REG's ticker is and the CUSIP is 7103065. A total of 5 filers reported holding NOVARTIS AG-REG in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,841,000 | +2.2% | 61,408 | +6.7% | 0.57% | +3.5% |
| Q2 2016 | $4,737,000 | +12.0% | 57,570 | -0.9% | 0.55% | +17.4% |
| Q1 2016 | $4,230,000 | -17.0% | 58,110 | 0.0% | 0.47% | -14.7% |
| Q4 2015 | $5,094,000 | -12.9% | 58,110 | -9.1% | 0.55% | -13.1% |
| Q3 2015 | $5,849,000 | -10.8% | 63,905 | -3.9% | 0.63% | +1.3% |
| Q2 2015 | $6,559,000 | -1.4% | 66,476 | -1.1% | 0.62% | +7.6% |
| Q1 2015 | $6,655,000 | +2.8% | 67,207 | -3.0% | 0.58% | -1.7% |
| Q4 2014 | $6,473,000 | +0.8% | 69,285 | -2.3% | 0.59% | +9.5% |
| Q2 2014 | $6,420,000 | – | 70,902 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boston Common Asset Management, LLC | 179,045 | $15,526,000 | 0.87% |
| Diversified Trust Co | 58,110 | $5,094,000 | 0.55% |
| Geneva Advisors, LLC | 19,455 | $1,684,000 | 0.03% |